Your go-to destination to spotlight your products and services while connecting with high-value leads in the microbiome space
Home > Industry > Matthew Henn (Seres Therapeutics): ‘Microbiome research will have a large impact on human health’
Watch our interview with Matthew Henn, Executive Vice President and Chief Scientific Officer of Seres Therapeutics.
Take full advantage of MicrobiomePost‘s features.
By submitting this form, you acknowledge that you have read and understand our Privacy Policy